Inventor · disambiguated record
Theodore Lee Roth
Also filed as: ROTH THEODORE · ROTH THEODORE L · ROTH THEODORE LEE
11 granted patents·9 pending applications·33 citations·filing 2013–2025
87Inventor score
Top patents by PatentIndex Score
20 records- 0196US11814624B2Targeted non-viral DNA insertionsUNIV CALIFORNIA·Filed 2021·Granted Nov 14, 2023·6 cites·33 claims
- 0295US11590171B2Targeted replacement of endogenous T cell receptorsUNIV CALIFORNIA·Filed 2022·Granted Feb 28, 2023·2 cites·16 claims
- 0395US11331346B2Targeted replacement of endogenous T cell receptorsUNIV CALIFORNIA·Filed 2021·Granted May 17, 2022·5 cites·18 claims
- 0495US11033584B2Targeted replacement of endogenous T cell receptorsUNIV CALIFORNIA·Filed 2019·Granted Jun 15, 2021·12 cites·31 claims
- 0592US11083753B1Targeted replacement of endogenous T cell receptorsROTH THEODORE LEE·Filed 2021·Granted Aug 10, 2021·8 cites·18 claims
- 0687US12234461B2Targeted non-viral DNA insertionsUNIV CALIFORNIA·Filed 2023·Granted Feb 25, 2025·0 cites·20 claims
- 0786US2025361287A1Targeted replacement of endogenous t cell receptorsUNIV CALIFORNIA·Filed 2025·Application pending·0 cites
- 0883US12398193B2Targeted replacement of endogenous T cell receptorsUNIV CALIFORNIA·Filed 2023·Granted Aug 26, 2025·0 cites·22 claims
- 0975US2025320504A1Targeted non-viral dna insertionsUNIV CALIFORNIA·Filed 2025·Application pending·0 cites
- 1074US2021388362A1Targeted non-viral dna insertionsUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 1168US2020362355A1Targeted non-viral dna insertionsUNIV CALIFORNIA·Filed 2018·Application pending·0 cites
- 1264US2025382340A1Dna constructs for improved t cell immunotherapyUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 1361US2025369021A1Genetic engineering of endogenous proteinsUNIV CALIFORNIA·Filed 2025·Application pending·0 cites
- 1459US12359179B2Compositions and methods for modifying a target nucleic acidUNIV CALIFORNIA·Filed 2019·Granted Jul 15, 2025·0 cites·16 claims
- 1556US2024392243A1Dna constructs for improved t cell immunotherapy of cancerUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 1653US2021207174A1Genetic engineering of endogenous proteinsUNIV CALIFORNIA·Filed 2019·Application pending·0 cites
- 1750US11639495B2Methods for selection and generation of genome edited T cellsUNIV CALIFORNIA·Filed 2019·Granted May 2, 2023·0 cites·26 claims
- 1847US2023066806A1Pooled knock-in screening and heterologous polypeptides co-expressed under the control of endogenous lociUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 1946US9308163B2Methods of treating and preventing diseases and disorders of the central nervous systemUS HEALTH·Filed 2013·Granted Apr 12, 2016·0 cites·7 claims
- 2042US9974801B2Methods of treating and preventing diseases and disorders of the central nervous systemUS HEALTH·Filed 2016·Granted May 22, 2018·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Theodore Lee Roth files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →